ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1144

Risk of Osteoporotic Fractures in Patients with Rheumatoid Arthritis and End Stage Renal Disease. Findings from the Usrds Database

Renee Peterkin-McCalman, Jennifer Waller, Brian Le, Alyce Oliver, Evan Manning, Stanley Nahman and Laura Carbone, Medical College of Georgia at Augusta University, Augusta, GA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: osteoporosis, renal disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) and End Stage Renal Disease (ESRD) are independent risk factors for osteoporotic fractures. Approximately one percent of persons with ESRD have RA. To our knowledge, there are no reports of whether persons with RA and ESRD are at greater risk for osteoporotic fracture than the general ESRD population. The purpose of this study was to determine whether RA is a risk factor for fractures in patients with ESRD and to characterize risk factors for these fractures.

Methods: A cohort study of ESRD patients with and without RA within the United States Renal Data System (USRDS) from 2006-2008 followed through 2011. The International Classification of Diseases, ninth revision (ICD-9) codes 714.0, 714.1, 714.2, 714.81 were utilized to identify those with a history of RA using the hospital claims data occurring on or before their dialysis start date. Fractures were identified using ICD-9 codes for fracture of the vertebrae (805.xx-806xx), upper (812.xx-817.xx), hip (820.xx-822.xx), lower extremity (823.xx-825.xx), pathological fracture (733.0, 733.1, 733.11, 733.12, 733.13, 733.14, 733.15, 733.16, 733.19) and stress fracture (733.93-733.98).

Results: There were 10,706 persons with ESRD and no history of RA in the analysis data set of whom 1570 (14.5%) had an incident fracture and 1040 persons with RA of whom 14.5% (266 persons) had an incident fracture. In multivariable adjusted models including age, gender, race, ethnicity, BMI, type of dialysis, smoking, alcohol use, vitamin D deficiency, hyperparathyroidism, secondary osteoporosis (of renal origin), hypogonadism, hyperthyroidism and prevalent fractures (within 5 years prior to start of dialysis), RA was a significant risk factor for any incident fracture (RR 1.83 (95% CI 1.59-2.11)) and incident hip fractures (RR 1.86 (95% CI 1.50-2.30)). Prevalent fractures (in the five years prior to initiation of dialysis) were significantly associated with all and hip fractures (p<0.01) and Black and Other race and BMI were significantly inversely associated with all and hip fractures.

Conclusion: In patients with RA and ESRD, the risk of osteoporotic fractures including hip and spine fractures is almost twofold greater than that of the general ESRD population. Risk factors for fractures in patients with RA and ESRD are similar to that of the general population. Attention to osteoporosis prevention is important in patients with RA and renal disease.


Disclosure: R. Peterkin-McCalman, None; J. Waller, None; B. Le, None; A. Oliver, None; E. Manning, None; S. Nahman, None; L. Carbone, None.

To cite this abstract in AMA style:

Peterkin-McCalman R, Waller J, Le B, Oliver A, Manning E, Nahman S, Carbone L. Risk of Osteoporotic Fractures in Patients with Rheumatoid Arthritis and End Stage Renal Disease. Findings from the Usrds Database [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/risk-of-osteoporotic-fractures-in-patients-with-rheumatoid-arthritis-and-end-stage-renal-disease-findings-from-the-usrds-database/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-osteoporotic-fractures-in-patients-with-rheumatoid-arthritis-and-end-stage-renal-disease-findings-from-the-usrds-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology